organic growth

Netflix abandons Warner Bros. Discovery acquisition bid, prioritizing organic growth through its 190M+ ad-supported users and content quality instead of transformative deals.

Netflix positions as strong 2026 buy after losing Warner Bros. deal, with 13% revenue growth expected and $113.09 price target implying 20% upside potential.

Caleres stock jumped 11% after beating Q4 earnings and providing optimistic 2026 guidance projecting profitability with $1.35-$1.65 adjusted EPS.

$BHP appoints 25-year veteran Brandon Craig as next CEO, prioritizing organic copper and potash growth while remaining open to selective acquisitions.

Virbac delivers 7.9% revenue growth and 16.3% adjusted EBIT margin in 2025, demonstrating strong operational execution amid robust product momentum.

HF Foods reports Q4 revenue growth of 2.2% to $1.23B and EBITDA rise of 6.9%, completes ERP digital transformation, and positions itself as consolidator in $50B Asian specialty foodservice market.

Global access solutions leader ASSA ABLOY reports record 2025 results despite tariffs and geopolitical headwinds, completing 23 acquisitions and launching new sustainability program through 2030.

ABM Industries grew Q1 FY2026 revenue 6.1% to $2.2B but net income fell 11.1% due to Technical Solutions margin pressures. Company reaffirms full-year outlook.

Netflix rebounds to $100/share after failed Warner Bros. Discovery deal, posting 16% revenue growth. Analysts see $150 potential amid streaming competition.

Mondelez trades down 10.6% despite posting 4% organic growth and 18% operating margins, offering a 3.32% yield with high-single-digit dividend growth potential.

Christian Dior reports €80.8B revenue with €17.7B operating profit amid global disruption, demonstrating luxury sector resilience.

Verisk reiterates medium-term targets: 6-8% organic revenue growth, 7-10% EBITDA growth, double-digit EPS expansion. Plans 75% free cash flow returns.

IonQ stock jumped 21% on Q4 results beating guidance by 55% and robust 2026 revenue outlook, though the company remains unprofitable.

White Mountains invests $125M in Bishop Street Underwriters, a RedBird Capital Partners portfolio company, supporting the MGA's $650M premium growth and market expansion efforts.

Stantec reports record $6.5B revenue, 10.7% YoY growth, and hits margin targets one year early. Strong backlog and dividend increase signal confidence.

Ferguson beat Q4 expectations with strong commercial growth offsetting residential weakness. Non-residential revenue surged 10% while residential declined 2% amid housing market challenges.

EPAM stock plunges 16.4% despite beating Q4 earnings due to weak 2026 guidance. Investors worry about AI's impact on consulting demand and growth deceleration.

BellRing Brands faces securities lawsuit alleging false statements about financial performance and growth. Class action covers November 2024 through August 2025 for affected investors.

Hormel divests commodity turkey business to Life-Science Innovations, shifting focus to higher-margin, value-added protein products for stronger growth prospects.

Medtronic beat Q3 sales estimates at $9.02B with 8.7% growth, reaffirming full-year guidance. Strong cardiovascular and diabetes segments drove performance despite stock decline.